The roles of ALYREF in NSCLC remain unclear although a recent study suggests that it, together with other m5C/m6A-related genes, could predict prognosis and immunotherapy efficacy in lung cancer [17]. The gene discussed is ALYREF; the disease is non-small cell lung carcinoma.